Geode Capital Management, LLC Galectin Therapeutics Inc Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 862,542 shares of GALT stock, worth $897,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
862,542
Previous 841,725
2.47%
Holding current value
$897,043
Previous $1.9 Million
24.66%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding GALT
# of Institutions
91Shares Held
9.65MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$2.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$1.63 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.23 Million0.01% of portfolio
-
Commonwealth Equity Services, LLC483KShares$502,5940.0% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$414,3080.01% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $61.8M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...